AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Telenet Group Holding NV

AGM Information Mar 24, 2017

4008_rns_2017-03-24_b7536859-e5b2-4532-a5db-f2b6005d8850.pdf

AGM Information

Open in Viewer

Opens in native device viewer

VOTING LETTER

Annual General Shareholders' Meeting

April 26, 2017 (3.00 p.m. CET)

This is an unofficial English translation, for information purposes only. Please only sign and return the original Dutch version.

To be returned
(together with Dutch version)
by mail at the latest on April
20, 2017
to:

Telenet Group Holding NV (the Company) Bart van Sprundel, Company Secretary Liersesteenweg 4, PB 54 2800 Mechelen, Belgium

The Undersigned (name and first name / Name of the Company)

………………………………………………………………………………………………………………………………………………

Residing / Registered Office

……………………………………………………………………………………………………………………………………………… ………………………………………………………………………………………………………………………………………………

Owner of

Shares of Telenet Group Holding NV

Votes by letter in the following way with respect to the Annual General Shareholders' Meeting, which will be held on Wednesday April 26, 2017 as from 3.00 p.m. CET

(Number)

My vote on the proposed resolutions is as follows: (please mark the appropriate boxes):

Annual General Shareholders' Meeting

1. Reports on the statutory financial statements Communication of and discussion on the annual report of the board of directors and the report of the statutory auditor on the statutory financial statements for the financial year ended on December 31, 2016.

2. Communication and approval of the statutory financial statements

Communication and approval of the statutory financial statements for the financial year ended on December 31, 2016, and of the proposed allocation of the result.

Proposed resolution: approval of the statutory financial statements for the financial year ended on December 31, 2016, including the allocation of the result as proposed by the board of directors.

I AGREE I DO NOT AGREE ABSTENTION

3. Reports on the consolidated financial statements Communication of and discussion on the annual report of the board of directors and the report of the statutory auditor on the consolidated financial statements for the financial year ended on December 31, 2016.

4. Communication of and discussion on the remuneration report

Communication of and discussion on the remuneration report, included in the annual report of the board of directors for the financial year ended on December 31, 2016.

Proposed resolution: approval of the remuneration report for the financial year ended on December 31, 2016.

I AGREE I DO NOT AGREE ABSTENTION

5. Communication of and discussion on the consolidated financial statements Communication of and discussion on the consolidated financial statements for the financial year ended on December 31, 2016.

6. Discharge from liability to the directors

Proposed resolution: to grant discharge from liability to the directors who were in office during the financial year ended on December 31, 2016, for the exercise of their mandate during said financial year.

a/ Bert De Graeve
(IDw Consult BVBA) I AGREE I DO NOT AGREE ABSTENTION
b/ Jo Van Biesbroeck (JoVB
BVBA) I AGREE I DO NOT AGREE ABSTENTION
c/ Christiane Franck
I AGREE I DO NOT AGREE ABSTENTION
d/ John Porter
I AGREE I DO NOT AGREE ABSTENTION
e/ Charles H. Bracken I AGREE I DO NOT AGREE ABSTENTION
f/ Diederik Karsten I AGREE I DO NOT AGREE ABSTENTION
g/ Manuel Kohnstamm
I AGREE I DO NOT AGREE ABSTENTION
h/ Jim Ryan I AGREE I DO NOT AGREE ABSTENTION
i/ Angela McMullen
I AGREE I DO NOT AGREE ABSTENTION
j/ Suzanne Schoettger
I AGREE I DO NOT AGREE ABSTENTION

Proposed resolution: to grant definitive discharge from liability to Mr. Balan Nair who was in office during the financial year ending on December 31, 2016 until his voluntary resignation on February 9, 2016, for the exercise of his mandate during said period.

I AGREE I DO NOT AGREE ABSTENTION

7. Discharge from liability to the statutory auditor

Proposed resolution: to grant discharge from liability to the statutory auditor for the exercise of his mandate during the financial year ended on December 31, 2016.

I AGREE I DO NOT AGREE ABSTENTION

8. Reappointment of director

Proposed resolution: to approve the reappointment of Mr. John Porter as a director of the Company, not compensated, for a term of four (4) years, with immediate effect and until the end of the annual general shareholders' meeting of 2021.

I AGREE I DO NOT AGREE ABSTENTION
  • 9. Communication of and discussion on the recommendation of the audit committee and the proposal of the board of directors regarding the appointment of the auditor Communication of and discussion on the recommendation of the audit committee and the proposal of the board of directors regarding the appointment of the auditor of the Company.
  • 10. Reappointment of the auditor Proposed resolution: reappointment of KPMG Bedrijfsrevisoren CVBA as the auditor of the Company, on proposal of the board of directors, after recommendation of the audit committee and after approval of the works council.
I AGREE I DO NOT AGREE ABSTENTION

11. Approval in accordance with Article 556 of the Belgian Company Code

Proposed resolution: Approval, in as far as needed and applicable, in accordance with Article 556 of the Belgian Company Code, of the terms and conditions of the performance shares plans and/or share option plans to (selected) employees issued by the Company, which may grant rights that either could have an impact on the Company's equity or could give rise to a liability or obligation of the Company in case of a change of control over the Company.

I AGREE I DO NOT AGREE ABSTENTION

12. Approval in relation to future share plans, option plans and warrant plans to be issued by the board of directors

Proposed resolution: In so far as necessary and required, approval that the board of directors of the company will issue new option- and/or warrant plans (together "options") in the future to the CEO, members of the Executive Team, employees of the Company and her subsidiaries or to any other persons who are self-employed (this, insofar possible and applicable under the authorized capital as approved by the general shareholders' meeting of April 26, 2017), and determines the conditions of these options, whereby the board of directors:

  • a) can issue and assign within a period of three (3) years as of April 26, 2017, up to maximum five million (5,000,000) options, under one or more optionor warrant plans;
  • b) can determine the conditions under which the options will become definitively acquired, which may be based on a mere time period or which can be conditional upon performance criteria and which can be determined for a period of three (3) years, or a shorter or longer period;
  • c) can determine as from when the options can be exercised, which can be after a period of three (3) years or a shorter or longer period;
  • d) if it decides to issue and assign options of which the definitive acquisition is conditional upon (general) performance criteria over a period longer than one (1) year, can determine the actual conditions for definitive acquisition on an annual basis (within the limits of the (longer period) general performance criteria) and in such case (i) for the first year, by the latest upon the assignment of options and (ii) for the other years, before March 1 of the year to which the specific criteria for definitive acquisition relate;

  • e) can provide that the number and the exercise price of the options will be amended as a result of a "corporate action", such as for example upon the issuance of an extraordinary dividend or upon a capital decrease; in so far as necessary and applicable, such power also relates to any outstanding or to be issued share plans with acquisition based on performance criteria;

  • f) can determine, if applicable, under which specified circumstances the definitive acquisition and the possibility to exercise the options can be accelerated (e.g. change of control); in this respect, the general shareholders' meeting approves, in accordance with article 556 of the Belgian Companies Code, that the board of directors issues and assigns options which are subject to an accelerated definitive acquisition if such change of control would occur;
  • g) in the event the definitive acquisition of the options is purely temporal, (i) not to consider such options as a "variable compensation" for purposes of article 520ter of the Belgian companies code, and (ii) not to consider as part of the "annual remuneration" for purposes of determining the relation "variable remuneration" versus "annual remuneration";
  • h) to consider (i) the assignment of a cash amount in the framework of a cash bonus plan based on performance and (ii) the assignment of shares in the framework of a share plan or option plan with acquisition based on performance criteria (so-called "performance shares/-options") as "variable compensation" for purposes of article 520ter of the Belgian Companies Code;
  • i) can determine that the shares acquired by employees in the framework of a share purchase plan (to which the board of directors can decide in the future), will remain freely transferable after termination of a period of two years (following the acquisition), during which they cannot be transferred.
I AGREE I DO NOT AGREE ABSTENTION

13. Remuneration of independent directors

Proposed resolution: upon recommendation of the remuneration and nomination committee of the board of directors of the Company, to (i) increase the fixed annual remuneration of the chairman of the board of directors from €100,000 to €120,000, (ii) increase the attendance fee for board meetings for the independent directors from €2,500 to €3,500, but with a maximum of €24,500 per year, (iii) introduce an attendance fee for the chairman of the Audit Committee for Audit Committee meetings at €4,000 per meeting, (iv) introduce an attendance fee for the other independent directors participating in the Audit Committee at 3,000 per meeting, and (v) to introduce an attendance fee for independent directors participating in the Remuneration & Nomination Committee at €2,000. All other remunerations remain unaffected.

I AGREE I DO NOT AGREE ABSTENTION

In case of amendments to the agenda and proposed additional resolutions as mentioned in article 533ter of the Belgian Company Code, the Company will publish an amended agenda with, as the case may be, additional agenda items and additional draft resolutions no later than on or before Tuesday, April 12, 2017 at the latest. In addition, the Company shall make amended forms available for votes by mail. Votes by mail that reach the Company prior to the publication of an amended agenda remain valid for the agenda items to which the votes by mail apply, subject, however, to applicable law and the further clarifications set out on the postal voting form. In accordance with the Belgian Company Code, a vote by letter regarding an agenda item for which a new proposed resolution was filed by a shareholder holding at least 3% of the shares, is null and void.

In case of amendments to a proposed resolution or a new proposed resolution:1

  • the Undersigned votes for the amended or new resolution
  • the Undersigned votes against the amended or new resolution
  • the Undersigned abstains from the vote on the amended or new resolution
  • the following person is appointed as special proxy holder, with power of substitution, to vote in the name of the Undersigned on the amended or new resolution: Mr./Mrs.

…………………………………………………………………………………………….

1 Absence of instructions on this form or to the proxy holder shall be tantamount to an instruction to vote for the amended or new resolution.

Done at ………………………………………………, on ……………………….…………………………. 2017.

Signature(s):…………………………………………………………………………………………………………………

Talk to a Data Expert

Have a question? We'll get back to you promptly.